Northwest Biotherapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.33-2.16-0.48-0.79-2.58-5.02-2.063.41-5.82-12.61-5.79-5.02
Price/Sales ratio
218.00143.0062.40173.46224.2849.16859.37608.41473.52408.63361.70224.28
Price/Book Value ratio
-9.04-53.18-1.46-1.23-1.95-2.71-3.05-4.93-6.22-16.80-4.75-2.71
Price/Cash Flow ratio
-5.80-3.16-0.69-1.59-2.67-3.71-34.56-15.96-15.10-14.71-11.53-3.71
Price/Free Cash Flow ratio
-3.58-2.91-0.64-1.59-2.65-3.67-28.66-13.79-14.31-13.83-10.93-3.67
Price/Earnings Growth ratio
-0.160.060.000.010.030.10-0.00-0.020.030.220.040.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-5789.75%-5829.84%-9543.82%-9874.70%-4306.31%-485.31%-2505.49%-1920.69%8.02%-1335.30%N/A-4306.31%
Operating Profit Margin
-6956.18%-7261.87%-12723.27%-16273.21%-10068.20%-1139.54%-6708.36%-5243.98%-3991.74%-2873.08%-3991.74%-10068.20%
Pretax Profit Margin
-9328.33%-6598.10%-12875.44%-21768.75%-8687.86%-842.15%-41039.58%17823.48%-6240.76%-3240.11%-6240.76%-8687.86%
Net Profit Margin
-9328.33%-6598.10%-12875.44%-21768.75%-8687.86%-978.09%-41701.39%17823.48%-8131.19%-3240.11%-6240.76%-8687.86%
Effective Tax Rate
13.20%-3.61%2.32%-4.44%-43.46%-16.14%-1.61%2.43%-30.29%N/AN/A-43.46%
Return on Assets
-232.08%-162.07%-151.61%-149.55%-145.10%-258.21%-1636.41%446.03%-436.89%-224.65%-335.31%-258.21%
Return On Equity
387.22%2453.82%302.70%154.65%75.90%54.10%148.33%-144.46%106.82%133.25%93.53%75.90%
Return on Capital Employed
968.89%-2101.93%337.31%141.00%91.82%85.64%24.77%56.30%70.95%320.13%70.95%85.64%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.07N/A
Quick Ratio
0.210.370.100.010.340.070.040.120.070.090.050.07
Cash ratio
0.190.330.080.000.310.000.020.110.050.040.050.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
66.2960.79222.54200.38404.00263.72138.27196.754.15K181.48N/A263.72
Cash Conversion Cycle
-66.29-60.79-222.54-200.38-404.00-263.72-138.27-196.75-4.15K-181.48N/A-404.00
Debt Ratios
Debt Ratio
0.370.160.590.640.681.430.450.810.691.475.080.68
Debt Equity Ratio
-0.61-2.52-1.19-0.66-0.35-0.30-0.04-0.26-0.17-0.87-1.24-0.30
Long-term Debt to Capitalization
-0.77N/A-0.12-0.21-0.04-0.17-0.02-0.25-0.04-0.76-0.08-0.08
Total Debt to Capitalization
-1.621.656.08-1.98-0.55-0.43-0.04-0.35-0.20-7.00-0.25-0.55
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-11.07N/A
Cash Flow to Debt Ratio
-2.51-6.66-1.75-1.16-2.05-2.42-2.14-1.17-2.41-1.30-2.01-2.05
Company Equity Multiplier
-1.66-15.14-1.99-1.03-0.52-0.20-0.09-0.32-0.24-0.59-0.24-0.52
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-37.53-45.20-89.32-108.61-83.94-13.21-24.85-38.10-31.35-27.76-31.35-83.94
Free Cash Flow / Operating Cash Flow Ratio
1.611.081.081.001.001.011.201.151.051.061.051.00
Cash Flow Coverage Ratio
-2.51-6.66-1.75-1.16-2.05-2.42-2.14-1.17-2.41-1.30-2.01-2.05
Short Term Coverage Ratio
-8.47-6.66-1.93-1.59-2.33-4.87-4.98-5.06-3.32-2.57-3.32-3.32
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A